Business Wire

MINDEROO-FOUNDATION

9.5.2022 08:23:07 CEST | Business Wire | Press release

Share
Global Plastic Watch: Satellite Eyes Pinpoint Waste From Space to Reduce Ocean Pollution

A cutting-edge new tool developed by Minderoo Foundation has identified thousands of waste sites across 25 countries for the first time using advanced satellite data technology and machine learning to measure piles of plastic waste from space.

Global Plastic Watch (globalplasticwatch.org ) is a tool which combines earth observation with artificial intelligence to create the first-ever near-real-time high-resolution map of plastic pollution. This is the largest open-source dataset of plastic waste across dozens of countries. The aim of the tool is to help authorities to better manage plastic leakage into the marine environment.

Global Plastic Watch uses remote sensing satellite imagery from the European Space Agency and a first-of-its-kind machine learned model created in collaboration with award winning Digital Product Agency for the Environment, Earthrise Media . The tool is able to determine the size and scale of land-based plastic waste sites, a major factor in fueling the growing problem of plastic pollution of the world’s rivers and oceans.

The data gathered provides a historical first and authoritative insight into one of the world’s most intractable environmental challenges – a deluge of plastic pollution which is threatening the oceans, harming communities, marine life, animal and human health. By using it, governments, industry and communities can evaluate and monitor the risk of land-based plastic waste sites, as well as prioritise investments in solutions.

The countries mapped so far include all of South-East Asia, Australia, and the countries identified by research published in Science Advances as accounting for high rates of plastic emissions into the ocean.

Dr Andrew Forrest AO, Chairman and Co-Founder of the Minderoo Foundation described data and transparency as important tools to fight plastic waste, and until now, it has been difficult to effectively identify and measure plastic waste build-up in a systematic, standardised way.

“Generally, the world has no idea how dangerous plastic waste is to the organic environment, particularly humans. The destination for every piece of plastic is nano-plastic, which has both poisonous and cutting attributes able to mutilate cells and even penetrate the human blood brain barrier,” Dr Forrest said.

“Preventing illegal and legal plastic waste stockpiles entering the oceanic environment is critical to limit this harm. Once in the ocean, through both mixing, absorption and ingestion by animals, this plastic will officially enter the human environment.

Using artificial Intelligence and satellite data, Minderoo Foundation has produced the first-ever map of plastic waste build up. Most of our data about plastic waste comes from models and estimates. Now our understanding is informed by real data that can be used to guide solutions.

Global Plastic Watch arms governments and researchers around the world with data that can better guide effective waste management interventions, ensuring land-based waste doesn’t end up in our oceans,” Dr Forrest said. “We want to work with governments to ensure this tool can also help to support policy change where needed.”

Dr Fabien Laurier, Lead for Technology and Innovation, and Ocean Conservation at Minderoo Foundation said some of the Global Plastic Watch findings were surprising.

“We know that land-based leakage contributes up to 91 per cent of the plastic waste that enters the ocean,” Dr Laurier said. “Global Plastic Watch has revealed that many large-scale waste sites across the first 25 countries we have mapped were previously undocumented and the number of sites is much higher than expected.”

The government of Indonesia is working with Minderoo Foundation to increase its recycling capacity to double recycling rates by developing capacity for an additional one million tonnes per year by 2025.

Dr Nani Hendiarti, Deputy for Environment and Forestry Management Coordination, Coordinating Ministry for Maritime Affairs and Investment, Indonesia, congratulated Minderoo Foundation on the public launch of the Global Plastic Watch.

“Global Plastic Watch is very helpful for identifying undocumented or illegal waste dump sites in Indonesia,” Dr Hendiarti said. “That has enabled us to prioritise areas in need of better waste management policies and actions. Therefore, it plays an integral role in accelerating the government’s waste management achievements across all regions in the country.”

Indonesian National Plastic Action Partnership (NPAP) Chair, Sri Indrastuti Hadiputranto, said tackling the challenge of plastic pollution in Indonesia, like in many other places in the world is going to require a collaborative effort from the public, private and civil society sectors, and its measurement is without exception.

“Global Plastic Watch is a data aggregator and monitoring platform on plastic waste,” Ms. Hadiputranto said. “It’s a timely innovation for policymakers, practitioners and advocates that believe in the importance of evidence-based policy making to advance our goal in reducing 70 per cent of ocean leakage by 2025. I believe more data-oriented innovations like Global Plastic Watch will lead us to a more sustainable policy outcome and improving collaborations in data collections in Indonesia.”

Global Plastic Watch is a tool aimed at supporting country-level efforts to understand the magnitudes and effects of land-based plastic waste sites, to enable them to better address undocumented sites and monitor those that pose environmental and health concerns. The data is also expected to guide direct investments in waste infrastructure in the areas that need it the most.

The development of the Global Plastic Watch tool follows the Plastic Waste Makers Index released in 2021, that revealed the true scale and sources of the global plastic waste crisis.

Globally, a 30 per cent increase in the production of single-use plastic is projected over the next five years. The Minderoo Foundation No Plastic Waste initiative believes this growth in production will lead to an extra three trillion items of throwaway plastic waste by 2025.

Global Plastic Watch will continue to work with partners to refine the Artificial Intelligence model and technology to further increase its accuracy as it expands its coverage to new sites and countries throughout 2022.

Global Plastic Watch site: globalplasticwatch.org
Global Plastic Watch project site: Minderoo.org/global-plastic-watch/

LINK TO PHOTOS (Password: k3YBL4TciY) | INTERVIEWS AND B-ROLL HERE | 2:17 VIDEO EDIT WITH ENGLISH NARRATION HERE |

About Minderoo Foundation:

Established by Andrew and Nicola Forrest in 2001, Minderoo Foundation is a modern philanthropic organisation seeking to break down barriers, innovate and drive positive, lasting change. Minderoo Foundation is proudly Australian, with key initiatives spanning from ocean research and ending slavery, to collaboration against cancer and building community projects.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye